Pharma is working to boost drug availability, not prices
By 
Victoria Jordan2025-10-16T11:48:00
Victoria Jordan, director of value and access policy at the Association of the British Pharmaceutical Industry (ABPI), explores how medicine pricing affects patient access, research investment, and the sustainability of the UK health system
Register with hsj.co.uk to read the rest of this article
Critical stories remain free for registered users
Certain articles and Insight pieces remain paying-subscriber only content
As a registered user you will get access to:
- Daily News: an essential email round-up of all the latest news, comment and best practice
- Breaking news headlines delivered directly to your inbox
- Limited access to hsj.co.uk
Already registered to HSJ? Sign in now